GB9625795D0 - Novel treatment - Google Patents

Novel treatment

Info

Publication number: GB9625795D0
Authority: GB; United Kingdom
Prior art keywords: novel treatment; novel; treatment
Prior art date: 1996-12-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GBGB9625795.1A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Ltd

Original Assignee

SmithKline Beecham Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-12

Filing date

1996-12-12

Publication date

1997-01-29

1996-12-12 Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd

1996-12-12 Priority to GBGB9625795.1A priority Critical patent/GB9625795D0/en

1997-01-29 Publication of GB9625795D0 publication Critical patent/GB9625795D0/en

1997-12-09 Priority to EP97953793A priority patent/EP0948325A2/en

1997-12-09 Priority to JP52623998A priority patent/JP2001510461A/en

1997-12-09 Priority to CA002274858A priority patent/CA2274858A1/en

1997-12-09 Priority to PCT/EP1997/006971 priority patent/WO1998025594A2/en

Status Pending legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GBGB9625795.1A 1996-12-12 1996-12-12 Novel treatment Pending GB9625795D0 (en)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
GBGB9625795.1A GB9625795D0 (en)	1996-12-12	1996-12-12	Novel treatment
EP97953793A EP0948325A2 (en)	1996-12-12	1997-12-09	Lamotrigine in the treatment and prophylaxis of migraine
JP52623998A JP2001510461A (en)	1996-12-12	1997-12-09	Lamotrigine in the treatment and prevention of migraine
CA002274858A CA2274858A1 (en)	1996-12-12	1997-12-09	Novel treatment
PCT/EP1997/006971 WO1998025594A2 (en)	1996-12-12	1997-12-09	Lamotrigine in the treatment and prophylaxis of migraine

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9625795.1A GB9625795D0 (en)	1996-12-12	1996-12-12	Novel treatment

Publications (1)

Publication Number	Publication Date
GB9625795D0 true GB9625795D0 (en)	1997-01-29

Family

ID=10804309

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9625795.1A Pending GB9625795D0 (en)	1996-12-12	1996-12-12	Novel treatment

Country Status (5)

Country	Link
EP (1)	EP0948325A2 (en)
JP (1)	JP2001510461A (en)
CA (1)	CA2274858A1 (en)
GB (1)	GB9625795D0 (en)
WO (1)	WO1998025594A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1524981B1 (en) *	2002-07-29	2009-03-11	Glaxo Group Limited	Sustained release formulations comprising lamotrigine
EP1438956A1 (en)	2003-01-16	2004-07-21	Newron Pharmaceuticals S.p.A.	Alpha-aminoamide derivatives useful as antimigraine agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9012311D0 (en) *	1990-06-01	1990-07-18	Wellcome Found	Pharmacologically active cns compounds
GB9012312D0 (en) *	1990-06-01	1990-07-18	Wellcome Found	Pharmacologically active cns compounds
GB9203483D0 (en) *	1992-02-19	1992-04-08	Wellcome Found	Anti-inflammatory compounds
US6133299A (en) *	1993-02-25	2000-10-17	Warner-Lambert Company	Methods for treating neurodegenerative diseases and disorders using N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas and other anticonvulsant compounds
FR2741879A1 (en) *	1995-12-05	1997-06-06	Esteve Labor Dr	FLUOROPHENYL-TRIAZINE AND PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS

1996
- 1996-12-12 GB GBGB9625795.1A patent/GB9625795D0/en active Pending
1997
- 1997-12-09 EP EP97953793A patent/EP0948325A2/en not_active Withdrawn
- 1997-12-09 CA CA002274858A patent/CA2274858A1/en not_active Abandoned
- 1997-12-09 WO PCT/EP1997/006971 patent/WO1998025594A2/en not_active Ceased
- 1997-12-09 JP JP52623998A patent/JP2001510461A/en active Pending

Also Published As

Publication number	Publication date
JP2001510461A (en)	2001-07-31
CA2274858A1 (en)	1998-06-18
EP0948325A2 (en)	1999-10-13
WO1998025594A3 (en)	1998-09-17
WO1998025594A2 (en)	1998-06-18

Publication	Publication Date	Title
GB9411080D0 (en)	1994-07-20	Treatment
GB9700899D0 (en)	1997-03-05	Novel treatment
GB9519033D0 (en)	1995-11-15	Treatment
ZA978359B (en)	1999-03-17	Novel treatment
GB9410512D0 (en)	1994-07-13	Novel treatment
ZA976593B (en)	1999-01-25	Novel treatment
GB9411635D0 (en)	1994-08-03	Novel treatment
GB9608657D0 (en)	1996-07-03	Novel treatment
GB2355006B (en)	2001-07-04	Materials treatment
GB9612752D0 (en)	1996-08-21	Novel treatment
GB9625795D0 (en)	1997-01-29	Novel treatment
GB9721692D0 (en)	1997-12-10	Novel treatment
GB9411632D0 (en)	1994-08-03	Novel treatment
GB9620085D0 (en)	1996-11-13	Cosmetic treatment
GB9721693D0 (en)	1997-12-10	Novel treatment
GB9614740D0 (en)	1996-09-04	Novel treatment
GB9604046D0 (en)	1996-04-24	Novel treatment
GB9616407D0 (en)	1996-09-25	Novel treatment
GB9610986D0 (en)	1996-07-31	Novel treatment
GB9614739D0 (en)	1996-09-04	Novel treatment
GB9616412D0 (en)	1996-09-25	Novel treatment
GB9616413D0 (en)	1996-09-25	Novel treatment
GB9616409D0 (en)	1996-09-25	Novel treatment
GB9616414D0 (en)	1996-09-25	Novel treatment
GB9619073D0 (en)	1996-10-23	Novel treatment